STOCK TITAN

Ambase SEC Filings

ABCP OTC Link

Welcome to our dedicated page for Ambase SEC filings (Ticker: ABCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

AmBase Corporation filings document material agreements, capital resources, governance matters, and risk disclosures for the company. The company’s 8-K reports disclose senior promissory notes for working capital, litigation funding arrangements, and going-concern language related to its ability to continue operations and pursue litigation tied to the 111 West 57th Property.

Proxy materials describe annual meeting procedures, director elections, advisory executive-compensation votes, record dates, and stockholder voting mechanics. Periodic reports referenced in company materials provide context on financial condition, operating results, risk factors, capital structure, and corporate affairs.

Rhea-AI Summary

AmBase Corporation reported the results of its annual meeting of stockholders held on May 27, 2026. Stockholders elected director Richard A. Bianco to a three-year term, with 50,116,832 votes for and 493,462 votes withheld, and no broker non-votes.

In a separate non-binding advisory vote, stockholders approved the compensation of the company’s named executive officers as described in the 2026 Proxy Statement, with 48,423,126 votes for, 1,989,983 against, 197,335 abstentions, and no broker non-votes. The terms of directors Richard A. Bianco, Jr., Alessandra F. Bianco and Scott M. Salant continued after the meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AmBase Corporation reported a net loss of $775 thousand for the three months ended March 31, 2026, narrowing from a $1,592 thousand loss a year earlier. Operating expenses fell to $678 thousand from $1,537 thousand, mainly on sharply lower professional and outside services.

Cash and cash equivalents increased to $533 thousand from $87 thousand at December 31, 2025, helped by related-party financing and new litigation funding. Total liabilities were $2,493 thousand, and stockholders’ equity was a deficit of $9,460 thousand. Management states there is substantial doubt about the Company’s ability to continue as a going concern without additional capital.

The business is effectively a single litigation-driven segment centered on disputes over the 111 West 57th Property. In March 2026, AmBase converted $4,000 thousand of loans from its CEO and $2,000 thousand from affiliate BARC into litigation funding agreements and secured further funding commitments tied to potential recoveries, which will reduce the Company’s share of any future litigation proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

AmBase Corporation calls its 2026 annual meeting for May 27, 2026 in Tarrytown, NY, asking shareholders to elect Chairman, President and CEO Richard A. Bianco to a new three-year board term and to approve, on an advisory basis, compensation for named executive officers.

The proxy details a highly concentrated ownership structure, with BARC Investments LLC, controlled by Alessandra F. Bianco and Richard A. Bianco Jr., holding about 59.9 million shares, or 70.5% of common stock as of March 20, 2026. Directors and officers as a group control 72.4%.

Executive pay is largely salary and benefits, with no bonuses, equity awards or stock plans in 2024–2025. In 2025, total compensation was $540,742 for Mr. Bianco, $280,589 for CFO John Ferrara and $164,129 for Treasurer Joseph R. Bianco.

The proxy also highlights several related-party arrangements tied to AmBase’s investment and litigation over the 111 West 57th Street property, including a 10% subordinated participation interest for Mr. Bianco and new 2026 litigation funding agreements under which Mr. Bianco and BARC provide up to $8 million of funding in exchange for priority and percentage interests in future litigation proceeds, reducing AmBase’s share of any recovery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

AmBase Corporation reported a net loss of $4.56 million for 2025, improving from a $6.62 million loss in 2024 as legal and professional fees fell. At year-end 2025, the company held only $87,000 of cash against $8.77 million of liabilities, resulting in a stockholders’ deficit of $8.69 million.

Auditors and management highlight substantial doubt about AmBase’s ability to continue as a going concern, given persistent losses and minimal liquidity. The business now largely revolves around disputes over its former equity investment in the 111 West 57th Street property, fully impaired in 2017, and related litigation.

To fund operations and litigation, AmBase relies on related-party loans and litigation funding agreements with its CEO and BARC Investments LLC, which convert prior loans into arrangements that claim priority over any future recoveries from the 111 West 57th litigations and further reduce AmBase’s share of potential proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

AmBase Corporation has entered into new litigation funding agreements to keep operating and continue its legal fight over the 111 West 57th Street property. Chairman and CEO Richard A. Bianco agreed to provide up to $6,000,000, including converting $4,000,000 of existing promissory notes and advancing two separate $1,000,000 cash payments for litigation costs and working capital.

BARC Investments LLC converted its $2,000,000 note into a similar litigation funding arrangement on a pari passu basis. These structures give funders significant rights to future litigation proceeds, further reducing AmBase’s share, while the company still faces going concern uncertainty and may need additional capital on potentially expensive terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

AmBase Corporation entered into a Senior Promissory Note under which Chairman, President and CEO Richard A. Bianco is lending the company $300,000 at an annual interest rate of 6.5% for working capital. The note is payable on the earlier of certain cash inflows sufficient to repay it, including any settlement of the 111 West 57th legal proceedings, or February 28, 2029.

The loan may, at Mr. Bianco’s option, be converted into a litigation funding agreement on terms equal to any third-party litigation funder. AmBase reiterates that its financial statements contain a going concern qualification and that it is actively evaluating additional funding and financing options, including potential litigation funding, equity or debt issuances, and loans, with no assurance of success or recovery from its 111 West 57th Property disputes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

AmBase Corporation entered into a $100,000 Senior Promissory Note with its Chairman, President and CEO, Richard A. Bianco, who is lending the company funds at 6.5% annual interest for working capital. The note is due on the earlier of the company receiving sufficient funds from any source to repay all amounts owed (with a potential exclusion for certain litigation funding tied to the 111 West 57th legal proceedings) or January 31, 2029. Mr. Bianco may instead convert the amount owed, plus interest, into a litigation funding agreement on the same terms as any such agreement the company signs with a third-party litigation funder.

The company reiterates that its financial statements include a going concern qualification and that it is actively considering a range of funding and financing options to support operations and the 111 West 57th Property litigation. Potential sources include third parties, existing shareholders and management, through structures such as litigation funding agreements, equity or debt securities, or loans. AmBase explains that litigation funding arrangements typically return the funder its initial capital first, plus an additional multiple of about 1.0x to 3.5x, and possibly extra fees, expenses, interest and a share of any recovery. The company also continues to explore options to realize value or sell its interest and rights in the 111 West 57th Property, while cautioning there is no assurance it can secure funding or prevail in its legal claims.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AmBase Corporation filed a current report to disclose a personnel change. Effective January 1, 2026, Joseph R. Bianco ceased to be an employee of AmBase Corporation. The report is presented under the item covering departures of directors or principal officers, elections of directors, and appointments of principal officers.

The company does not add new financial information in this report and instead points readers to its prior periodic reports for a fuller discussion of its financial condition, results of operations, risk factors, and forward-looking statements. The filing is signed on behalf of AmBase by John Ferrara, Vice President, Chief Financial Officer and Controller.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

AmBase Corporation reported that its Chairman, President and CEO, Richard A. Bianco, has provided the company with a $300,000 senior promissory note to supply working capital. The loan carries a 6.5% annual interest rate and is due on the earlier of the company receiving sufficient funds from any source to repay all principal and interest, potentially excluding certain litigation funding for the 111 West 57th legal proceedings, or December 31, 2028.

Mr. Bianco may convert amounts owed under the note into a litigation funding agreement on the same terms as any such agreement the company enters with a litigation funder. AmBase reiterates that its financial statements include a going concern qualification and that it is actively evaluating additional funding options, including litigation funding agreements, equity or debt securities, and loans. It is exploring up to $5 million of additional litigation funding, where funders typically recover their capital first plus a multiple of 1.0x to 3.5x and possible extra fees or a share of any recovery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

AmBase Corporation entered into a Senior Promissory Note under which its Chairman, President and CEO, Richard A. Bianco, is lending the company $100,000 at an interest rate of 6.5% per annum for working capital. The note is due on the earlier of the company receiving funds sufficient to repay all amounts due, including from any settlement of the 111 West 57th legal proceedings, or November 30, 2028.

Mr. Bianco may also convert amounts owed under the note into a litigation funding agreement on a pari-passu basis with any third-party litigation funders. AmBase reiterates that its financial statements include a going concern qualification and that it is actively evaluating additional funding options, including litigation funding agreements for up to $5 million, potential equity or debt securities, and loans, while emphasizing there is no assurance it will obtain such financing or prevail in its 111 West 57th Property litigation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Ambase (ABCP) SEC filings are available on StockTitan?

StockTitan tracks 12 SEC filings for Ambase (ABCP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ambase (ABCP)?

The most recent SEC filing for Ambase (ABCP) was filed on May 29, 2026.